Cargando…

Effect of Linagliptin on Glycemic Control in Chinese Patients with Newly-Diagnosed, Drug-Naïve Type 2 Diabetes Mellitus: A Randomized Controlled Trial

BACKGROUND: This study aimed to evaluate the efficacy and safety of linagliptin (a novel dipeptidyl peptidase (DPP)-4 inhibitor) on glucose metabolism and β-cell function in Chinese patients with newly-diagnosed, drug-naïve type 2 diabetes mellitus (T2DM). MATERIAL/METHODS: Newly-diagnosed and drug-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Wenjun, Li, Ying, Chen, Xiong, Lin, Dini, Xiang, Songying, Shen, Feixia, Gu, Xuemei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2015
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4571530/ https://www.ncbi.nlm.nih.gov/pubmed/26350766 http://dx.doi.org/10.12659/MSM.894026

Ejemplares similares

Linagliptin Increases Incretin Levels, Lowers Glucagon, and Improves Glycemic Control in Type 2 Diabetes Mellitus
por: Rauch, Thomas, et al.
Publicado: (2012)

Greater Glycemic Burden Is Associated with Further Poorer Glycemic Control in Newly-Diagnosed Type 2 Diabetes Mellitus Patients
por: Wen, Wei-Lun, et al.
Publicado: (2022)

Management of Patients with Newly Diagnosed Diabetic Mellitus: Ophthalmologic Outcomes in Intensive versus Conventional Glycemic Control
por: Lam, Pun Yuet, et al.
Publicado: (2021)

Influence of Dapagliflozin on Glycemic Variations in Patients with Newly Diagnosed Type 2 Diabetes Mellitus
por: Li, Feng-fei, et al.
Publicado: (2016)

Medication adherence and glycemic control among newly diagnosed diabetes patients
por: Lin, Lee-Kai, et al.
Publicado: (2017)

Effect of Poor Glycemic Control in Newly Diagnosed Patients with Smear-Positive Pulmonary Tuberculosis and Type-2 Diabetes Mellitus
por: Mahishale, Vinay, et al.
Publicado: (2017)

Antihypertensive treatment improves glycemic control in patients with newly diagnosed type 2 diabetes mellitus: A prospective cohort study
por: Li, Jung-Chi, et al.
Publicado: (2022)

The risk factors of glycemic control, blood pressure control, lipid control in Chinese patients with newly diagnosed type 2 diabetes _ A nationwide prospective cohort study
por: Cai, Xiaoling, et al.
Publicado: (2019)

Improvement of beta-cell function in conjunction with glycemic control after medical nutrition therapy in newly-diagnosed type 2 diabetes mellitus
por: Takahara, Mitsuyoshi, et al.
Publicado: (2022)

Association Between 25-Hydroxyvitamin D and Epicardial Adipose Tissue in Chinese Non-Obese Patients with Type 2 Diabetes
por: Chen, Xiong, et al.
Publicado: (2017)

Oral glucose lowering with linagliptin and metformin compared with linagliptin alone as initial treatment in Asian patients with newly diagnosed type 2 diabetes and marked hyperglycemia: Subgroup analysis of a randomized clinical trial
por: Ma, Ronald CW, et al.
Publicado: (2017)

No Significant Changes of Glycemic Control and Renal Function in Patients with Advanced-Stage Diabetic Kidney Disease by Switching from Linagliptin to Teneligliptin
por: Hirai, Keiji, et al.
Publicado: (2021)

The remission phase in adolescents and young adults with newly diagnosed type 1 diabetes mellitus: prevalence, predicting factors and glycemic control during follow-up
por: Yazidi, Meriem, et al.
Publicado: (2022)

The clinical application of linagliptin in Asians
por: Cao, Chu-qing, et al.
Publicado: (2015)

Population Pharmacokinetics and Pharmacodynamics of Linagliptin in Patients with Type 2 Diabetes Mellitus
por: Retlich, Silke, et al.
Publicado: (2015)

Sleep disturbances in newly diagnosed treatment-naïve patients with Wilson’s disease
por: Jernajczyk, Wojciech, et al.
Publicado: (2022)

Microbial Dynamics in Newly Diagnosed and Treatment Naïve IBD Patients in the Mediterranean
por: Rausch, Philipp, et al.
Publicado: (2023)

Effects of Dapagliflozin on Endothelial Function, Renal Injury Markers, and Glycemic Control in Drug-Naïve Patients with Type 2 Diabetes Mellitus
por: Kong, Sung Hye, et al.
Publicado: (2019)

Effects of personalized diets by prediction of glycemic responses on glycemic control and metabolic health in newly diagnosed T2DM: a randomized dietary intervention pilot trial
por: Rein, Michal, et al.
Publicado: (2022)

Glycemic and Cholesterol Control Versus Single-Goal Control in US Veterans with Newly Diagnosed Type 2 Diabetes: A Retrospective Observational Study
por: Shi, Lizheng, et al.
Publicado: (2015)

An open-label pilot study on preventing glucocorticoid-induced diabetes mellitus with linagliptin
por: Miyawaki, Yoshia, et al.
Publicado: (2018)

Association between glycemic control and birthweight with glycated albumin in Chinese women with gestational diabetes mellitus
por: Li, Hua‐Ping, et al.
Publicado: (2015)

Gut bacterial profile in patients newly diagnosed with treatment-naïve Crohn’s disease
por: Ricanek, Petr, et al.
Publicado: (2012)

Lifestyle modification intervention improves glycemic control in Mongolian adults who are overweight or obese with newly diagnosed type 2 diabetes
por: Sonomtseren, S., et al.
Publicado: (2016)

Association between smoking and glycemic control in men with newly diagnosed type 2 diabetes: a retrospective matched cohort study
por: Sia, Hon-Ke, et al.
Publicado: (2022)

Divergent Effects of Glycemic Control and Bariatric Surgery on Circulating Concentrations of TMAO in Newly Diagnosed T2D Patients and Morbidly Obese
por: Canyelles, Marina, et al.
Publicado: (2022)

Impaired β Cell Function in Chinese Newly Diagnosed Type 2 Diabetes Mellitus with Hyperlipidemia
por: Ma, Yuhang, et al.
Publicado: (2014)

Oscillatory pattern of glycemic control in patients with diabetes mellitus
por: Vasquez-Muñoz, Manuel, et al.
Publicado: (2021)

Linagliptin: from bench to bedside
por: Doupis, John
Publicado: (2014)

Real-World Glycemic Lowering Effectiveness of Linagliptin Among Adults with Type 2 Diabetes by Age, Renal Function, and Race
por: Hoogwerf, Byron J., et al.
Publicado: (2020)

Refractive errors in patients with newly diagnosed diabetes mellitus
por: Yarbağ, Abdülhekim, et al.
Publicado: (2015)

SKAP2, a Candidate Gene for Type 1 Diabetes, Regulates β-Cell Apoptosis and Glycemic Control in Newly Diagnosed Patients
por: Fløyel, Tina, et al.
Publicado: (2021)

Teneligliptin As an Initial Therapy for Newly Diagnosed, Drug Naive Subjects With Type 2 Diabetes
por: Kutoh, Eiji, et al.
Publicado: (2014)

Effects of Liraglutide Combined with Short-Term Continuous Subcutaneous Insulin Infusion on Glycemic Control and Beta Cell Function in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A Pilot Study
por: Ke, Weijian, et al.
Publicado: (2016)

Gastric Inhibitory Polypeptide Receptor Methylation in Newly Diagnosed, Drug-Naïve Patients with Type 2 Diabetes: A Case-Control Study
por: Canivell, Silvia, et al.
Publicado: (2013)

Effect of metformin monotherapy on serum lipid profile in statin-naïve individuals with newly diagnosed type 2 diabetes mellitus: a cohort study
por: Lin, Szu Han, et al.
Publicado: (2018)

Proportion and Characteristics of the Subjects with Low Muscle Mass and Abdominal Obesity among the Newly Diagnosed and Drug-Naïve Type 2 Diabetes Mellitus Patients
por: Kim, Jung A, et al.
Publicado: (2019)

Beneficial Effects of Insulin on Glycemic Control and β-Cell Function in Newly Diagnosed Type 2 Diabetes With Severe Hyperglycemia After Short-Term Intensive Insulin Therapy
por: Chen, Harn-Shen, et al.
Publicado: (2008)

A Cross-Sectional Study of Atherosclerosis in Newly Diagnosed Patients with Ketosis-Prone Type 2 Diabetes
por: Wang, Yuxia, et al.
Publicado: (2022)

Survival and glycemic control in patients with coexisting melanoma and diabetes mellitus
por: Karlin, Nina J, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ts05fn76ls8rcosifnue6qlocf